News Quantified

THTX – theratechnologies inc. - common shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROI

Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIV

Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024

Theratechnologies Inc. (NASDAQ: THTX) was upgraded by analysts at Research Capitl to a "strong-buy" rating.

Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update [Canadian Business Journal (Canada)]

SPECULATIVE BUY

MACKIE RESEARCH

Form 20-F Theratechnologies Inc. For: Nov 30

Form 6-K Theratechnologies Inc. For: Feb 26

Form 6-K Theratechnologies Inc. For: Feb 21

Form SCHEDULE 13G/A Theratechnologies Inc. Filed by: MORGAN STANLEY

Form 6-K Theratechnologies Inc. For: Feb 14

Top News Gainers

2/4 Theratechnologies Signs Agreements With Massachusetts General Hospital and Dr. Steven Grinspoon 19.1%

3/3 Theratechnologies Inc. (NASDAQ: THTX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $95.50 price target on the stock. 17.7%

4/14 Theratechnologies Announces Financial Results for the First Quarter of 2020 11.8%

10/14 REMINDER - Tesamorelin Study Results on NAFLD Published in Lancet HIV 9.9%

4/16 Theratechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 6.8%

10/21 Theratechnologies Provides Details About R&D Day Webcast 4.7%

3/11 Visceral Fat is a Predictor of Liver Fibrosis and Fibrosis Progression in People Living With HIV 3.8%

3/13 Form 6-K Theratechnologies Inc. For: Mar 13 3.4%

1/10 Theratechnologies Inc. (NASDAQ: THTX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 3.4%

12/19 Form 6-K Theratechnologies Inc. For: Dec 19 2.6%

Top News Decliners

11/15 Form F-10/A Theratechnologies Inc. -12.3%

10/10 Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing -7.5%

4/15 Theratechnologies Inc. (THTX) Q1 2020 Earnings Call Transcript [The Motley Fool] -5.4%

12/2 Theratechnologies Inc. (NASDAQ: THTX) is now covered by analysts at Canaccord Genuity. They set a "buy" rating on the stock. -5.1%

11/22 Form EFFECT Theratechnologies Inc. -4.1%

3/31 Form 6-K Theratechnologies Inc. For: Mar 31 -3.6%

11/25 Theratechnologies Starts Commercialization of New EGRIFTA SV?? in the United States -2.6%

10/11 Form F-X Theratechnologies Inc. Filed by: Theratechnologies Inc. -2.0%

2/18 Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2019 -1.8%

3/10 Form 6-K Theratechnologies Inc. For: Mar 10 -1.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day